Atlas Trials

CART-19 Immunotherapy in Mantle Cell Lymphoma

Clinical trial NCT02081937 · UNKNOWN

Trial details

NCT number
NCT02081937
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematopoietic/Lymphoid CancerNon-hodgkin Lymphoma,B CellMantle Cell Lymphoma
Start date
2014-03-01
Primary completion
2018-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.